You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 4, April 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

β-Lactamase—Producing Bacteria Recovered After Clinical Failures With Various Penicillin Therapy

Itzhak Brook, MD

Arch Otolaryngol. 1984;110(4):228-231.


Abstract

• The presence of β-lactamase—producing bacteria in clinical specimens was investigated in 185 children with orofacial or respiratory tract infections. All of these patients failed to respond to antimicrobial therapy, including penicillins, that was administered to 148 (80%) of them. β-Lactamase—producing aerobic and anaerobic bacteria were detected in 75 (40.5%) of the 185 children. The β-lactamase—producing strains included all 11 strains of the Bacteroides fragilis group, 30 (45.4%) of the 66 strains of the Bacteroides melaninogenicus group, five (41.7%) of the 12 strains of Bacteroides oralis, and 41 (97.6%) of 42 strains of Staphylococcus aureus. All β-lactamase—producing Bacteroides strains were resistant to penicillin as compared with the non-β-lactamase—producing strains. Clinical cure was achieved after surgical drainage and a change in antimicrobial therapy in most of the patients. In treatment of orofacial and respiratory tract infections, the clinician should consider the presence of β-lactamase—producing Bacteroides sp and S aureus as a possible cause of clinical failure with various penicillin therapies.

(Arch Otolaryngol 1984;110:228-231)



Author Affiliations

From the Departments of Pediatrics and Otolaryngology, Uniformed Services University for the Health Sciences, Bethesda, Md.


Footnotes

Accepted for publication Oct 12, 1983.

Reprint requests to the Naval Medical Research Institute, National Naval Medical Center, Bethesda, MD 20814 (Dr Brook).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Penicillin Failure in the Treatment of Acute and Relapsing Tonsillopharyngitis Is Associated With Copathogens and Alteration of Microbial Balance: A Role for Cephalosporins
Brook
CLIN PEDIATR 2007;46:17S-24S.
ABSTRACT  

Meta-analysis of Cephalosporin Versus Penicillin Treatment of Group A Streptococcal Tonsillopharyngitis in Children
Casey and Pichichero
Pediatrics 2004;113:866-882.
ABSTRACT | FULL TEXT  

Efficacy of Penicillin vs. Amoxicillin in Children with Group A Beta Hemolytic Streptococcal Tonsillopharyngitis
Curtin-Wirt et al.
CLIN PEDIATR 2003;42:219-225.
ABSTRACT  

Penicillin and Clindamycin Therapy in Recurrent Tonsillitis: Effect of Microbial Flora
Foote and Brook
Arch Otolaryngol Head Neck Surg 1989;115:856-859.
ABSTRACT  

Emergence and Persistence of {beta}-Lactamase--Producing Bacteria in the Oropharynx Following Penicillin Treatment
Brook
Arch Otolaryngol Head Neck Surg 1988;114:667-670.
ABSTRACT  

Microbiology of Retropharyngeal Abscesses in Children
Brook
Arch Pediatr Adolesc Med 1987;141:202-204.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.